Guobang Pharma Holds Steady Amid Pharma Slump: 15‑Month Profit Drop, 15% Q3 Decline
Guobang Pharma’s latest trading snapshot shows a stable price at CNY 15.17, with Q3 earnings down amid rising costs but strong R&D focus on specialty therapies.
2 minutes to read